This webinar will present a set of case studies on:
- Integrated single and multiple ascending dose studies combining healthy volunteer and POC investigations
- Real-time adaptive GMP manufacturing to enable dose, formulation and product changes within a clinical protocol in response to emerging clinical data
- Continuous supply of clinical trial material (CTM) to global clinical sites post-Phase I, avoiding the need for tech transfer and scale up prior to Phase II
There may be many networking opportunities at the First-in-Human to Proof-Of-Concept: Addressing Development Challenges and Accelerating Timelines. Find out more in the event details below.
|Conference/Event Dates:||07/12/2016 - 07/12/2016|
|Conference/Event Hours:||2pm EDT|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Professional Healthcare|
|Cost to Attend:||Free|
|Audience:||EVPs, VPs, Directors, Heads, Managers, Principal Scientists from Clinical Development / Clinical Pharmacology, Formulation Research and Development functions, and CMC groups.|
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.